mopidamol has been researched along with Carcinoma, Small Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cornell, CJ; Forcier, RJ; Forman, WB; Henderson, WG; Martin, JF; Rickles, FR; Van Eeckhout, JP; Zacharski, LR | 1 |
Meehan, KR; Moritz, TE; Rickles, FR; Zacharski, LR | 1 |
Barnes, S; Bartholomew, MJ; Dixon, R; Gordon, R; Harvey, HA; Lipton, A; Valdivia, D; Walker, B; Warzawski, N; White-Hershey, D | 1 |
1 review(s) available for mopidamol and Carcinoma, Small Cell
Article | Year |
---|---|
Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer.
Topics: Adenocarcinoma; Animals; Anticoagulants; Blood Platelets; Carcinoma, Small Cell; Clinical Trials as Topic; Colonic Neoplasms; Double-Blind Method; Humans; Lung Neoplasms; Mopidamol; Neoplasms; Neoplasms, Experimental; Pyrimidines; Random Allocation | 1982 |
2 trial(s) available for mopidamol and Carcinoma, Small Cell
Article | Year |
---|---|
Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer.
Topics: Adenocarcinoma; Animals; Anticoagulants; Blood Platelets; Carcinoma, Small Cell; Clinical Trials as Topic; Colonic Neoplasms; Double-Blind Method; Humans; Lung Neoplasms; Mopidamol; Neoplasms; Neoplasms, Experimental; Pyrimidines; Random Allocation | 1982 |
Chemotherapy plus RA233 in the treatment of oat cell lung cancer.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Double-Blind Method; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mopidamol; Podophyllotoxin; Prospective Studies; Pyrimidines; Random Allocation; Vincristine | 1989 |
1 other study(ies) available for mopidamol and Carcinoma, Small Cell
Article | Year |
---|---|
Pretreatment fibrinogen levels are associated with response to chemotherapy in patients with small cell carcinoma of the lung: Department of Veterans Affairs Cooperative Study 188.
Topics: Carcinoma, Small Cell; Cohort Studies; Drug Resistance; Fibrinogen; Fibrinolysin; Fibrinopeptide A; Fibrinopeptide B; Humans; Lung Neoplasms; Mopidamol; Randomized Controlled Trials as Topic; Regression Analysis; Thrombin | 1995 |